Markets › United States › NYSE › RDY

Dr Reddy's Laboratories Ltd

NYSE:RDYHealthcare

$13.08+0.08%At closeAt close · Tue 20 Oct · ≈ AED 48.04 · Market cap $10.92B · Next earnings Fri 23 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	50.8%	53.1%	56.7%	58.6%	58.5%	52.8%	—	—
Operating margin	16.9%	13.7%	23.2%	24.3%	22.1%	13.8%	13.8%	+0.0 pts
Net margin	9.1%	11.0%	18.3%	19.9%	17.4%	12.8%	12.8%	+0.0 pts
EBITDA margin	20.9%	21.0%	30.3%	31.7%	29.7%	23.6%	—	—
Return on equity	9.8%	12.4%	19.5%	19.8%	17.0%	12.2%	12.1%	−0.1 pts
Return on assets	6.4%	8.0%	14.0%	14.4%	11.5%	7.9%	7.9%	+0.0 pts
Return on capital employed	17.3%	14.8%	24.2%	23.2%	19.8%	12.1%	—	—
Debt / equity	0.2×	0.2×	0.1×	0.1×	0.1×	0.2×	0.2×	−0.9%
Debt / assets	11.4%	11.6%	4.2%	5.2%	9.5%	13.3%	—	—
Interest coverage	0.4×	30.8×	40.0×	39.6×	25.4×	12.4×	—	—
Current ratio	1.8×	1.9×	2.4×	2.6×	1.9×	1.8×	1.8×	+0.0%
Quick ratio	1.2×	1.4×	1.8×	1.9×	1.4×	1.3×	—	—
Cash ratio	0.2×	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.7×	0.7×	0.8×	0.7×	0.7×	0.6×	—	—
Inventory turnover	2.0×	2.0×	2.2×	1.8×	1.9×	2.2×	—	—
Receivables turnover	3.0×	2.7×	3.0×	2.9×	3.0×	3.6×	—	—
Dividend payout	1,785.9%	17.6%	11.0%	11.9%	11.8%	15.5%	—	—